The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global cGMP Plasmid DNA Manufacturing Service Market Research Report 2024
Synopsis
The global cGMP Plasmid DNA Manufacturing Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The growing interest and investment in gene therapy contribute to the demand for GMP plasmid DNA manufacturing. Plasmid DNA is often used as a vector in gene therapy applications.
Technological advancements in biotechnology enhance the efficiency and capabilities of plasmid DNA manufacturing processes, driving the market forward.
This report aims to provide a comprehensive presentation of the global market for cGMP Plasmid DNA Manufacturing Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding cGMP Plasmid DNA Manufacturing Service.
Report Scope
The cGMP Plasmid DNA Manufacturing Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global cGMP Plasmid DNA Manufacturing Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the cGMP Plasmid DNA Manufacturing Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River Laboratories
Patheon
AGC Biologics
Creative Biolabs
Synbio Technologies
Aldevron
Takara Bio
Recipharm
Eurogentec
Akron Biotech
Catalent Biologics
Xpress Biologics
Esco Aster
Biovian
GenScript ProBio
Andelyn Biosciences
WuXi Advanced Therapies
Waisman Biomanufacturing
GenScript Biotech
Segment by Type
Research Grade Plasmid DNA
Commercial Grade Plasmid DNA
Segment by Application
Cancers
Inherited Disorders
Viral Infections
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of cGMP Plasmid DNA Manufacturing Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global cGMP Plasmid DNA Manufacturing Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The growing interest and investment in gene therapy contribute to the demand for GMP plasmid DNA manufacturing. Plasmid DNA is often used as a vector in gene therapy applications.
Technological advancements in biotechnology enhance the efficiency and capabilities of plasmid DNA manufacturing processes, driving the market forward.
This report aims to provide a comprehensive presentation of the global market for cGMP Plasmid DNA Manufacturing Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding cGMP Plasmid DNA Manufacturing Service.
Report Scope
The cGMP Plasmid DNA Manufacturing Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global cGMP Plasmid DNA Manufacturing Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the cGMP Plasmid DNA Manufacturing Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River Laboratories
Patheon
AGC Biologics
Creative Biolabs
Synbio Technologies
Aldevron
Takara Bio
Recipharm
Eurogentec
Akron Biotech
Catalent Biologics
Xpress Biologics
Esco Aster
Biovian
GenScript ProBio
Andelyn Biosciences
WuXi Advanced Therapies
Waisman Biomanufacturing
GenScript Biotech
Segment by Type
Research Grade Plasmid DNA
Commercial Grade Plasmid DNA
Segment by Application
Cancers
Inherited Disorders
Viral Infections
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of cGMP Plasmid DNA Manufacturing Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global cGMP Plasmid DNA Manufacturing Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Research Grade Plasmid DNA
1.2.3 Commercial Grade Plasmid DNA
1.3 Market by Application
1.3.1 Global cGMP Plasmid DNA Manufacturing Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Cancers
1.3.3 Inherited Disorders
1.3.4 Viral Infections
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global cGMP Plasmid DNA Manufacturing Service Market Perspective (2019-2030)
2.2 cGMP Plasmid DNA Manufacturing Service Growth Trends by Region
2.2.1 Global cGMP Plasmid DNA Manufacturing Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 cGMP Plasmid DNA Manufacturing Service Historic Market Size by Region (2019-2024)
2.2.3 cGMP Plasmid DNA Manufacturing Service Forecasted Market Size by Region (2025-2030)
2.3 cGMP Plasmid DNA Manufacturing Service Market Dynamics
2.3.1 cGMP Plasmid DNA Manufacturing Service Industry Trends
2.3.2 cGMP Plasmid DNA Manufacturing Service Market Drivers
2.3.3 cGMP Plasmid DNA Manufacturing Service Market Challenges
2.3.4 cGMP Plasmid DNA Manufacturing Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top cGMP Plasmid DNA Manufacturing Service Players by Revenue
3.1.1 Global Top cGMP Plasmid DNA Manufacturing Service Players by Revenue (2019-2024)
3.1.2 Global cGMP Plasmid DNA Manufacturing Service Revenue Market Share by Players (2019-2024)
3.2 Global cGMP Plasmid DNA Manufacturing Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by cGMP Plasmid DNA Manufacturing Service Revenue
3.4 Global cGMP Plasmid DNA Manufacturing Service Market Concentration Ratio
3.4.1 Global cGMP Plasmid DNA Manufacturing Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by cGMP Plasmid DNA Manufacturing Service Revenue in 2023
3.5 cGMP Plasmid DNA Manufacturing Service Key Players Head office and Area Served
3.6 Key Players cGMP Plasmid DNA Manufacturing Service Product Solution and Service
3.7 Date of Enter into cGMP Plasmid DNA Manufacturing Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 cGMP Plasmid DNA Manufacturing Service Breakdown Data by Type
4.1 Global cGMP Plasmid DNA Manufacturing Service Historic Market Size by Type (2019-2024)
4.2 Global cGMP Plasmid DNA Manufacturing Service Forecasted Market Size by Type (2025-2030)
5 cGMP Plasmid DNA Manufacturing Service Breakdown Data by Application
5.1 Global cGMP Plasmid DNA Manufacturing Service Historic Market Size by Application (2019-2024)
5.2 Global cGMP Plasmid DNA Manufacturing Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America cGMP Plasmid DNA Manufacturing Service Market Size (2019-2030)
6.2 North America cGMP Plasmid DNA Manufacturing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America cGMP Plasmid DNA Manufacturing Service Market Size by Country (2019-2024)
6.4 North America cGMP Plasmid DNA Manufacturing Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe cGMP Plasmid DNA Manufacturing Service Market Size (2019-2030)
7.2 Europe cGMP Plasmid DNA Manufacturing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe cGMP Plasmid DNA Manufacturing Service Market Size by Country (2019-2024)
7.4 Europe cGMP Plasmid DNA Manufacturing Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific cGMP Plasmid DNA Manufacturing Service Market Size (2019-2030)
8.2 Asia-Pacific cGMP Plasmid DNA Manufacturing Service Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific cGMP Plasmid DNA Manufacturing Service Market Size by Region (2019-2024)
8.4 Asia-Pacific cGMP Plasmid DNA Manufacturing Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America cGMP Plasmid DNA Manufacturing Service Market Size (2019-2030)
9.2 Latin America cGMP Plasmid DNA Manufacturing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America cGMP Plasmid DNA Manufacturing Service Market Size by Country (2019-2024)
9.4 Latin America cGMP Plasmid DNA Manufacturing Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa cGMP Plasmid DNA Manufacturing Service Market Size (2019-2030)
10.2 Middle East & Africa cGMP Plasmid DNA Manufacturing Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa cGMP Plasmid DNA Manufacturing Service Market Size by Country (2019-2024)
10.4 Middle East & Africa cGMP Plasmid DNA Manufacturing Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Company Detail
11.1.2 Charles River Laboratories Business Overview
11.1.3 Charles River Laboratories cGMP Plasmid DNA Manufacturing Service Introduction
11.1.4 Charles River Laboratories Revenue in cGMP Plasmid DNA Manufacturing Service Business (2019-2024)
11.1.5 Charles River Laboratories Recent Development
11.2 Patheon
11.2.1 Patheon Company Detail
11.2.2 Patheon Business Overview
11.2.3 Patheon cGMP Plasmid DNA Manufacturing Service Introduction
11.2.4 Patheon Revenue in cGMP Plasmid DNA Manufacturing Service Business (2019-2024)
11.2.5 Patheon Recent Development
11.3 AGC Biologics
11.3.1 AGC Biologics Company Detail
11.3.2 AGC Biologics Business Overview
11.3.3 AGC Biologics cGMP Plasmid DNA Manufacturing Service Introduction
11.3.4 AGC Biologics Revenue in cGMP Plasmid DNA Manufacturing Service Business (2019-2024)
11.3.5 AGC Biologics Recent Development
11.4 Creative Biolabs
11.4.1 Creative Biolabs Company Detail
11.4.2 Creative Biolabs Business Overview
11.4.3 Creative Biolabs cGMP Plasmid DNA Manufacturing Service Introduction
11.4.4 Creative Biolabs Revenue in cGMP Plasmid DNA Manufacturing Service Business (2019-2024)
11.4.5 Creative Biolabs Recent Development
11.5 Synbio Technologies
11.5.1 Synbio Technologies Company Detail
11.5.2 Synbio Technologies Business Overview
11.5.3 Synbio Technologies cGMP Plasmid DNA Manufacturing Service Introduction
11.5.4 Synbio Technologies Revenue in cGMP Plasmid DNA Manufacturing Service Business (2019-2024)
11.5.5 Synbio Technologies Recent Development
11.6 Aldevron
11.6.1 Aldevron Company Detail
11.6.2 Aldevron Business Overview
11.6.3 Aldevron cGMP Plasmid DNA Manufacturing Service Introduction
11.6.4 Aldevron Revenue in cGMP Plasmid DNA Manufacturing Service Business (2019-2024)
11.6.5 Aldevron Recent Development
11.7 Takara Bio
11.7.1 Takara Bio Company Detail
11.7.2 Takara Bio Business Overview
11.7.3 Takara Bio cGMP Plasmid DNA Manufacturing Service Introduction
11.7.4 Takara Bio Revenue in cGMP Plasmid DNA Manufacturing Service Business (2019-2024)
11.7.5 Takara Bio Recent Development
11.8 Recipharm
11.8.1 Recipharm Company Detail
11.8.2 Recipharm Business Overview
11.8.3 Recipharm cGMP Plasmid DNA Manufacturing Service Introduction
11.8.4 Recipharm Revenue in cGMP Plasmid DNA Manufacturing Service Business (2019-2024)
11.8.5 Recipharm Recent Development
11.9 Eurogentec
11.9.1 Eurogentec Company Detail
11.9.2 Eurogentec Business Overview
11.9.3 Eurogentec cGMP Plasmid DNA Manufacturing Service Introduction
11.9.4 Eurogentec Revenue in cGMP Plasmid DNA Manufacturing Service Business (2019-2024)
11.9.5 Eurogentec Recent Development
11.10 Akron Biotech
11.10.1 Akron Biotech Company Detail
11.10.2 Akron Biotech Business Overview
11.10.3 Akron Biotech cGMP Plasmid DNA Manufacturing Service Introduction
11.10.4 Akron Biotech Revenue in cGMP Plasmid DNA Manufacturing Service Business (2019-2024)
11.10.5 Akron Biotech Recent Development
11.11 Catalent Biologics
11.11.1 Catalent Biologics Company Detail
11.11.2 Catalent Biologics Business Overview
11.11.3 Catalent Biologics cGMP Plasmid DNA Manufacturing Service Introduction
11.11.4 Catalent Biologics Revenue in cGMP Plasmid DNA Manufacturing Service Business (2019-2024)
11.11.5 Catalent Biologics Recent Development
11.12 Xpress Biologics
11.12.1 Xpress Biologics Company Detail
11.12.2 Xpress Biologics Business Overview
11.12.3 Xpress Biologics cGMP Plasmid DNA Manufacturing Service Introduction
11.12.4 Xpress Biologics Revenue in cGMP Plasmid DNA Manufacturing Service Business (2019-2024)
11.12.5 Xpress Biologics Recent Development
11.13 Esco Aster
11.13.1 Esco Aster Company Detail
11.13.2 Esco Aster Business Overview
11.13.3 Esco Aster cGMP Plasmid DNA Manufacturing Service Introduction
11.13.4 Esco Aster Revenue in cGMP Plasmid DNA Manufacturing Service Business (2019-2024)
11.13.5 Esco Aster Recent Development
11.14 Biovian
11.14.1 Biovian Company Detail
11.14.2 Biovian Business Overview
11.14.3 Biovian cGMP Plasmid DNA Manufacturing Service Introduction
11.14.4 Biovian Revenue in cGMP Plasmid DNA Manufacturing Service Business (2019-2024)
11.14.5 Biovian Recent Development
11.15 GenScript ProBio
11.15.1 GenScript ProBio Company Detail
11.15.2 GenScript ProBio Business Overview
11.15.3 GenScript ProBio cGMP Plasmid DNA Manufacturing Service Introduction
11.15.4 GenScript ProBio Revenue in cGMP Plasmid DNA Manufacturing Service Business (2019-2024)
11.15.5 GenScript ProBio Recent Development
11.16 Andelyn Biosciences
11.16.1 Andelyn Biosciences Company Detail
11.16.2 Andelyn Biosciences Business Overview
11.16.3 Andelyn Biosciences cGMP Plasmid DNA Manufacturing Service Introduction
11.16.4 Andelyn Biosciences Revenue in cGMP Plasmid DNA Manufacturing Service Business (2019-2024)
11.16.5 Andelyn Biosciences Recent Development
11.17 WuXi Advanced Therapies
11.17.1 WuXi Advanced Therapies Company Detail
11.17.2 WuXi Advanced Therapies Business Overview
11.17.3 WuXi Advanced Therapies cGMP Plasmid DNA Manufacturing Service Introduction
11.17.4 WuXi Advanced Therapies Revenue in cGMP Plasmid DNA Manufacturing Service Business (2019-2024)
11.17.5 WuXi Advanced Therapies Recent Development
11.18 Waisman Biomanufacturing
11.18.1 Waisman Biomanufacturing Company Detail
11.18.2 Waisman Biomanufacturing Business Overview
11.18.3 Waisman Biomanufacturing cGMP Plasmid DNA Manufacturing Service Introduction
11.18.4 Waisman Biomanufacturing Revenue in cGMP Plasmid DNA Manufacturing Service Business (2019-2024)
11.18.5 Waisman Biomanufacturing Recent Development
11.19 GenScript Biotech
11.19.1 GenScript Biotech Company Detail
11.19.2 GenScript Biotech Business Overview
11.19.3 GenScript Biotech cGMP Plasmid DNA Manufacturing Service Introduction
11.19.4 GenScript Biotech Revenue in cGMP Plasmid DNA Manufacturing Service Business (2019-2024)
11.19.5 GenScript Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
